Masupirdine (SUVN-502): An Update on the Phase-3 Clinical Development Program Targeting Agitation in Patients with Dementia of Alzheimer’s Type

Cognitive Trajectory in Concordant Clinical and Neuropathological Diagnosis of Alzheimer's Disease Compared to Clinical Mimics - A Retrospective Analysis of NACC Data (2005-2023)